Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2010-01-05 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Response Genetics Distribution Agreement 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated January 6, 2010, regarding the execution of an Exclusive Distribution Agreement between Genetic Technologies Limited and Response Genetics, Inc. It details the terms and scope of the agreement, the products involved, and background information about both companies. There is no financial data, no mention of financial results, no regulatory certifications, no voting results, no management changes, and no legal proceedings. The document is a corporate announcement about a business partnership and distribution agreement. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial report. It is a general corporate announcement about a commercial agreement, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2010-01-05 English
US Annual Report on Form 20-F 144 pages ?Kb
Annual Report Classification · 100% confidence The document is identified as a Form 20-F filed with the United States Securities and Exchange Commission (SEC). It is explicitly labeled as an "Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934" for the fiscal year ended June 30, 2009. The content includes a detailed table of contents with sections typical of an annual report, such as financial statements, risk factors, management discussion, and corporate governance. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is the full annual report, not just an announcement or certification. Therefore, the appropriate classification is Annual Report (10-K). FY 2009
2009-12-28 English
Exclusive Option Agreement 1 page ?Kb
M&A Activity Classification · 90% confidence The document is an ASX announcement dated December 17, 2009, regarding the execution of an exclusive option agreement to acquire a breast cancer diagnostic product. It describes the nature of the transaction, due diligence, and strategic intent but does not contain financial statements, detailed financial results, or regulatory certifications. The document is relatively short (2922 characters) and serves as a corporate announcement about a potential acquisition rather than a full merger filing or detailed financial report. It is not a merger proxy statement or tender offer filing, nor is it a full annual or interim report. It is an announcement about a capital transaction (acquisition option) but not a financing or capital structure update per se. The best fitting category is M&A Activity (TAR) as it relates to an acquisition agreement announcement, but since it is an option agreement and not a completed merger or acquisition, it still fits under M&A Activity announcements. Confidence is high given the clear description of the transaction type and the nature of the document as an announcement.
2009-12-16 English
Cancellation of Options 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated December 3, 2009, regarding the forfeiture and cancellation of 500,000 options previously issued to former employees. It provides specific details about the options such as ASX code, number, exercise price, and expiry date. The content is a brief announcement about a capital-related event (forfeiture of options) rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed analysis, nor is it a report publication or certification. The nature of the announcement fits best under capital structure changes or financing activities, specifically related to options forfeiture, which aligns with the Capital/Financing Update category (CAP). The document length is short (1209 characters), consistent with an announcement rather than a full report.
2009-12-02 English
Materials for 2009 AGM 28 pages ?Kb
AGM Information Classification · 95% confidence The document is an ASX announcement dated November 25, 2009, providing materials for the 2009 Annual General Meeting (AGM) of Genetic Technologies Limited. It includes resolutions to be considered at the AGM such as re-election of directors, remuneration report adoption, and appointment of auditor. It also contains a detailed presentation covering business activities, financial highlights, strategic goals, and product information. The presence of proxy vote counts and detailed agenda items confirms this is the actual AGM materials, not just an announcement of the meeting or a report publication notice. The document length (over 10,000 characters) and content depth support classification as AGM Information rather than a brief announcement or other report type.
2009-11-24 English
Director Appointment/Resignation 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated November 25, 2009, regarding the resignation of Mr. Fred Bart as Chairman and Company Director. It discusses a change in the company's board of directors and mentions the withdrawal of a resolution related to his re-election at the Annual General Meeting. There is no financial data, no report attached or referenced as being published, and the content focuses solely on management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement of a management change, not a full report or other filing type.
2009-11-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.